Korolowicz, Kyle E. P. Iyer, Radhakrishnan Czerwinski, Stefanie Suresh, Manasa Yang, Junming Padmanabhan, Seetharamaiyer Sheri, Anjaneyulu Pandey, Rajendra K. Skell, Jeffrey Marquis, Judith K. Kallakury, Bhaskar V. Tucker, Robin D. Menne, Stephan SB 9200 treatment is associated with dose-dependent, transient increases of SDH but not of other liver enzymes. <p>Changes in mean serum levels of SDH, AST and ALT in response to SB 9200 treatment at a low (<b>A</b>) or high dose (<b>B</b>). Changes in mean serum WHV DNA relative to T<sub>0</sub> is plotted on the left y-axis. Error bars represent the standard error of the mean.</p> SB 9200 treatment;HBV;SB 9200 Treatment;Host Innate Immunity Associated;serum WHV surface antigen;hepatitis B virus;SB 9200;1.6 log 10 declines;IFN;sensor proteins;NOD;RNA;woodchuck hepatitis virus;3.7 log 10 reductions;serum WHV DNA 2016-08-23
    https://plos.figshare.com/articles/figure/SB_9200_treatment_is_associated_with_dose-dependent_transient_increases_of_SDH_but_not_of_other_liver_enzymes_/3754305
10.1371/journal.pone.0161313.g005